- Kyowa Kirin Receives Positive CHMP Opinion for the Self-administration of CRYSVITA® ▼ (burosumab) to Treat X-Linked Hypophosphataemia (XLH), a Rare Metabolic Bone Disorder
- Twist Bioscience and Kyowa Kirin Partner for GPCR Antibody Discovery
- Kyowa Kirin Announces Positive Phase 2 Results for KHK4083 in Patients with Moderate to Severe Atopic Dermatitis
As of last trade
Kyowa Kirin Co Ltd (4151:DEU) traded at 24.60, -6.11% below its 52-week high of 26.20, set on May 06, 2021.
20.20Dec 18 202026.20May 06 2021
Markit short selling activity
|Market cap||1.73tn JPY|
|EPS (TTM)||85.78 |
|Annual div (ADY)||0.3467 |
|Annual div yield (ADY)||1.46%|
|Div ex-date||Dec 29 2020|
|Div pay-date||Mar 25 2021|
|Next div ex-date||Jun 29 2021|
|Next div pay-date||--|
Data delayed at least 15 minutes, as of May 14 2021 10:30 BST.